Malignant mesothelioma is an uncommon form of cancer typically associated with prolonged asbestos exposure. A rare yet serious disease, malignant mesothelioma attacks the mesothelium (membrane lining the heart sac and the lung and abdominal cavities), typically causing death within one to two years of diagnosis. Malignant mesothelioma types include:
A plethora of treatment options are available for the 2,000 to 3,000 cases of malignant mesothelioma diagnosed yearly throughout the United States.
There are three traditional ways to treat malignant mesothelioma:
Doctors will often use a combination of two or more treatments (chemotherapy or radiotherapy is commonly used to stunt the growth of a malignant tumor prior to a surgical procedure).
Surgery: Surgical treatment of malignant mesothelioma is the physical removal of a cancerous tumor. The most proactive approach to treating any form of cancer, surgery is split into three categories:
Chemotherapy: Treatment of mesothelioma using chemical substances is commonly referred to as chemotherapy. Cancer cells divide at a faster rate than normal cells, fostering a rapid spread of the disease. Although chemotherapy is not a curative procedure, it works to slow the spread of cancer cells throughout the body. Chemotherapy is used for various purposes in treating malignant mesothelioma:
Cisplatin has been used in the treatment of cancers since the 1970s when studies demonstrated its effectiveness in combating various sarcomas implanted in rats. A platinum-based chemotherapy drug, cisplatin is currently used for the treatment of sarcomas, carcinomas, lymphomas and germ cell tumors. Cisplatin was the first of a group of platinum-based chemotherapy drugs that now includes carboplatin and oxaliplatin. Although a traditional chemotherapy drug, cisplatin is often used in conjunction with various new treatment modalities or chemotherapy drugs. Both cisplatin and carboplatin are being tested in conjunction with pemetrexed (Alimta) for the treatment of malignant mesothelioma.
Radiation Therapy: Commonly called radiotherapy, radiation therapy uses high-energy rays such as x-rays to kill malignant mesothelioma cells. Somewhat similar to chemotherapy, radiotherapy is not typically viewed as a curative procedure; rather, it is used in combination with surgical procedures and for the purpose of treating the symptoms. Usually, radiotherapy is applied solely to a localized area of concern, as opposed to the entire body.
With the financial support of the Mesothelioma Research Foundation of America, Dr. Parkash Gill, M.D. has developed a non-chemotherapy, non-radiation modified molecule that treats cancer by attacking the blood vessels that feed the tumor thereby diminshing the cancerous tumor and eventually killing the tumor. Dr. Gill's molecule is known as Veglin, it has finished Phase II Clinical Trials and is now being scheduled for Phase III Clinical Trials.
For questions related to the foundation and to make contributions please contact:
(800) 909-Meso (6376)
3011 Townsgate Rd, Suite 450
Westlake Village, CA 91361
For more information and other questions contact:
©2016 Mesothelioma Research Foundation Of America